HopeStage
Back to all studies
RecruitingNCT05976347

Medication or usual support for depression identified after orthopaedic surgery

About this titleRead the official source — NCT05976347

Researchers are comparing Fluoxetine 20 MG and Duloxetine 30 MG to find out how the approaches affect depression symptoms in people with depression.

Medication studyAges 18+United States
The study in practice

Understand this study

What is this study about?

Researchers are comparing Fluoxetine 20 MG and Duloxetine 30 MG to find out how the approaches affect depression symptoms in people with depression.

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
Winston-SalemSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
Wake Forest University Health Sciences
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05976347
Official title
Show the full official title

Identifying and Treating Depression in the Orthopaedic Trauma Population

Recruitment & locations

Currently recruiting

Winston-Salem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing Fluoxetine 20 MG and Duloxetine 30 MG to find out how the approaches affect depression symptoms in people with depression.

Who is behind this study?

The study sponsor is Wake Forest University Health Sciences, a university.

Does this study involve medication?

Yes. The study involves medication, including Fluoxetine 20 MG and Duloxetine 30 MG.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies